Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
- PMID: 29033621
- PMCID: PMC5628702
- DOI: 10.2147/EB.S125311
Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
Abstract
Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common form of ischemic optic neuropathy and the second most common optic neuropathy. Patients are generally over the age of 50 years with vasculopathic risk factors (eg, diabetes mellitus, hypertension, and obstructive sleep apnea). The exact mechanism of NAION is not fully understood. In addition, several treatment options have been proposed. This article summarizes the current literature on the diagnosis, treatment, and management of NAION.
Keywords: anterior ischemic optic neuropathy; ischemic optic neuropathy; nonarteritic anterior ischemic optic neuropathy.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
-
- Barros AE, Amram AL, Derham AM, Smith SV, Lee AG. Management of ischemic optic neuropathies. Expert Rev Ophthalmol. 2017;12(2):99–109.
-
- Lee AG, Brazis PW. Clinical Pathways in Neuro-Ophthalmology: An Evidence-Based Approach. Stuttgart, Germany: Thieme; 2003.
-
- Nazari H, Berry S, Sadaka A, Lee AG. Managing NAION. Specialist. 2017;15:201715.
-
- Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nonarteritic anterior ischemic optic neuropathy: role of nocturnal arterial hypotension. Arch Ophthalmol. 1997;115(7):942–945. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
